Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-020020
Filing Date
2021-08-16
Accepted
2021-08-16 13:16:07
Documents
50
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 639107
2 ex31-1.htm EX-31.1 8084
3 ex31-2.htm EX-31.2 8095
4 ex32-1.htm EX-32.1 3902
5 ex32-2.htm EX-32.2 4068
  Complete submission text file 0001493152-21-020020.txt   3479643

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bblg-20210630.xsd EX-101.SCH 33549
7 XBRL CALCULATION FILE bblg-20210630_cal.xml EX-101.CAL 28255
8 XBRL DEFINITION FILE bblg-20210630_def.xml EX-101.DEF 124001
9 XBRL LABEL FILE bblg-20210630_lab.xml EX-101.LAB 267252
10 XBRL PRESENTATION FILE bblg-20210630_pre.xml EX-101.PRE 200164
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 490273
Mailing Address 2 BURLINGTON WOODS DRIVE, SUITE 100, BURLINGTON MA 01803
Business Address 2 BURLINGTON WOODS DRIVE, SUITE 100, BURLINGTON MA 01803 (781) 552-4452
Bone Biologics Corp (Filer) CIK: 0001419554 (see all company filings)

EIN.: 421743430 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53078 | Film No.: 211176331
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies